Selwyn Ho is the CEO of Signadori Bio, a company developing novel immunotherapies for solid tumours. Educated at INSEAD in corporate strategy, he specializes in leading and advising early-stage biotech companies. Colleagues frequently describe him as strategic, insightful, and a supportive leader.
As a strategic advisor to Antengene, he supported the successful out-licensing of an oncology drug to UCB in a deal valued at up to $1. 1 billion.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.